The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research. The research funded will focus on exploiting novel protein kinases that regulate MYC protein stability to cause MYC loss, … Continue reading Channing Der Granted 2018 NCI Outstanding Investigator Award
GRANTEE: KIRSTEN BRYANT, PHD University of North Carolina at Chapel Hill Research Project: Exploiting pancreatic cancer cell metabolism for therapeutic gain Award: 2015 Pancreatic Cancer Action Network – AACR Pathway to Leadership Grant Award Period: October 1, 2015 – September 30, 2020 Amount: $600,000 Biographical Highlights Dr. Bryant is currently a postdoctoral researcher in the laboratory … Continue reading Kirsten Bryant awarded Pathway to Leadership Grant
A research team led by Drs. Adrienne D. Cox and Channing J. Der (members of the UNC Lineberger Program in Molecular Therapeutics) is one of the first recipients of an NCI U01 grant on New Approaches to Synthetic Lethality for Mutant KRas-Dependent Cancers. Their team, which also includes Drs. Ben Major at UNC, Kris Wood … Continue reading Cox and Der lead team to $2M+ NCI U01 grant
Channing Der awarded NCI grant to pursue drug discovery Channing J. Der, PhD, UNC Lineberger member and Kenan Distinguished Professor in the Department of Pharmacology at the UNC School of Medicine, was awarded a five-year NIH R01 grant entitled "Biological Activity of RAS Oncogenes". This grant will support his studies to pursue drug discovery for … Continue reading New Grants awarded in the Der Lab
April 22, 2015 -- The Pancreatic Cancer Action Network and the American Association for Cancer Research announced April 16 that UNC Lineberger's Channing Der, PhD, and two co-principal investigators were chosen to receive a $1 million grant for pancreatic cancer research. Earlier this year, Der was also announced as the recipient of a grant from … Continue reading Lineberger News: Der pulls in two grants for pancreatic cancer research
Meagan Ryan, of the Der and Cox labs, was recently awarded a NIH fellowship grant (F31) for her application entitled "Defining the Role of ERK1 and ERK2 in pancreatic cancer". The current focus of Ryan's research is ERK1/2 signalling in pancreatic cancer and melanoma. Well done Meagan!
Nicole Baker, of the Der Lab and a graduate student in the Pharmacology department, was awarded a NIH Fellowship grant, worth over $75,000 for three years. Congratulations Nicole!